Search clinical trials for: ADT + Enzalutamide
Total 4747 results
-
Asan Medical CenterUnknownCastration-resistant Prostate CancerKorea, Republic of
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
NantCell, Inc.CompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Colon Cancer | Thyroid CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaboratorsTerminatedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
Aragon Pharmaceuticals, Inc.No longer availableProstatic NeoplasmsColombia, Brazil, Mexico
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteDendreonRecruitingProstate Cancer | Metastatic Prostate CancerUnited States
-
The Netherlands Cancer InstituteCompletedMetastasis | Prostate Cancer MetastaticNetherlands
-
PfizerAstellas Pharma IncActive, not recruitingProstatic NeoplasmsUnited States
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Oscar Goodman, Jr.Comprehensive Cancer Centers of NevadaWithdrawn
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
University of Missouri-ColumbiaNot yet recruitingProsthetic-joint InfectionUnited States
-
PfizerAstellas Pharma IncActive, not recruiting
-
Medical College of WisconsinCompletedProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
AbbVie (prior sponsor, Abbott)Prostate Cancer Clinical Trials ConsortiumCompleted
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
AbbVie (prior sponsor, Abbott)CompletedGastric CancerUnited States, Korea, Republic of
-
Wake Forest University Health SciencesRecruitingRecurrent Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid NeoplasmUnited States
-
Hansoh BioMedical R&D CompanyNot yet recruitingAdvanced Solid Tumor
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingProstate Cancer | Bone MetastasesItaly
-
University of UtahCompleted
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, United Kingdom
-
University of California, DavisNational Cancer Institute (NCI); Astellas Pharma Inc; Medivation, Inc.Active, not recruitingEnzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerProstate CancerUnited States
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, United States, Australia, Brazil, France, Germany, Taiwan, Denmark, China, Netherlands, Portugal, Japan, Canada, Finland, Italy, Hungary, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
AbbVieCompleted
-
Mark Garzotto, MDMerck Sharp & Dohme LLC; Astellas Pharma IncRecruitingProstate CancerUnited States
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsCompletedProstate CancerUnited States
-
Carolina Research Professionals, LLCAstellas Pharma IncCompletedProstate Carcinoma Metastatic to the BoneUnited States
-
University of MichiganNational Cancer Institute (NCI)CompletedCancer of ProstateUnited States
-
European Organisation for Research and Treatment...BayerActive, not recruitingProstate CancerBelgium, Spain, France, Italy
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsNetherlands
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, Germany, Poland, Hungary, Slovakia
-
Jin LiNot yet recruitingRelapsed Ovarian Cancer
-
Musculoskeletal Transplant FoundationUnknownBreast ReconstructionUnited States
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
AbbottCompleted
-
AbbVieCompletedHepatic ImpairmentUnited States, New Zealand
-
Laboratoires NEGMAUnknown